...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694

Hopefully more $$$ details etc tmr. Hopefully this isn't another Rvx Eversana type program. 

 "Zenith Epigenetics Ltd. ("Zenith" or the "Company"), a global leader in epigenetics"
a global leader sitting at .12 Pennie's.

Expectecing greater detail tomorrow but it looks & sounds good in this moment.

glta 

Share
New Message
Please login to post a reply